Ebola virus disease

• Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial

  2024 Emerging Microbes & Infections article Medicine Viral Infections and Outbreaks Research Open access

  4

  citations
• Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial

  2024 Human Vaccines & Immunotherapeutics article Medicine Viral Infections and Outbreaks Research Open access cited by 2 patents

  8

  citations
• Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study

  2024 Vaccines article Medicine Viral Infections and Outbreaks Research Open access

  7

  citations
• Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP

  2023 iScience article Medicine Viral Infections and Outbreaks Research Open access

  8

  citations
• Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda

  2023 Vaccine article Medicine Viral Infections and Outbreaks Research Open access

  11

  citations
• Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

  2023 The Lancet Global Health article Medicine Viral Infections and Outbreaks Research Open access

  18

  citations
• Ebola virus–like particles reprogram cellular metabolism

  2023 Journal of Molecular Medicine article Medicine Viral Infections and Outbreaks Research Open access

  10

  citations
• Model-based evaluation of the impact of prophylactic vaccination applied to Ebola epidemics in Sierra Leone and Democratic Republic of Congo

  2022 BMC Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access

  9

  citations
• Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels

  2022 Vaccines article Medicine Viral Infections and Outbreaks Research Open access

  25

  citations
• Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo

  2022 BMJ Open article Medicine Viral Infections and Outbreaks Research Open access

  30

  citations
• Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen

  2021 npj Vaccines article Medicine Viral Infections and Outbreaks Research Open access

  10

  citations

11 results